Impacts of cytogenetic categories in the Revised International Prognostic Scoring System on the prognosis of primary myelodysplastic syndromes: results of a single-center study

References

• Komrokji RS, Zhang L, Bennett JM. Myelodysplastic syndromes classification and risk stratification. Hematol Oncol Clin North Am 2010;24:443–457.
   PubMed Web of Science ®Google Scholar
• Cazzola M, Malcovati L. Prognostic classification and risk assessment in myelodysplastic syndromes. Hematol Oncol Clin North Am 2010;24:459–468.
   PubMed Web of Science ®Google Scholar
• Garcia-Manero G. Prognosis of myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program 2010:330–337.
   PubMedGoogle Scholar
• Bennett JM, Catovsky D, Daniel MT, . Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189–199.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100:2292–2302.
   PubMed Web of Science ®Google Scholar
• Brunning RD, Orazi A, Germing U, . Myelodysplastic syndromes/neoplasms, overview. In: Swerdlow SH, Campo E, Harris NL, editors. WHO classification of tumours of hamatopoietic and lymphoid tissues. Lyon, France: IARC; 2008. p 88.
   Google Scholar
• Mufti GJ, Stevens JR, Oscier DG, . Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 1985;59:425–433.
   PubMed Web of Science ®Google Scholar
• Sanz GF, Sanz MA, Vallespi T, . Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 1989;74:395–408.
   PubMed Web of Science ®Google Scholar
• Aul C, Gattermann N, Heyll A, . Primary myelodysplastic syndromes:analysis of prognostic factors in 235 patients and proposal for an improved scoring system. Leukemia 1992;6:52–59.
   PubMed Web of Science ®Google Scholar
• Morel P, Hebbar M, Lai JL, . Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 1993;9:1315–1323.
   Google Scholar
• Toyama K, Ohyashiki K, Yoshida Y, . Clinical implications of chromosome abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia 1993;7:499–508.
   PubMed Web of Science ®Google Scholar
• Parlier V, van Melle G, Beris P, . Prediction of 18-month survival in patients with primary myelodysplastic syndrome. A regression model and scoring system based on the combination of chromosome findings and the Bournemouth score. Cancer Genet Cytogenet 1995;81:158–165.
   PubMed Web of Science ®Google Scholar
• Greenberg P, Cox C, LeBeau MM, . International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079–2088.
   PubMed Web of Science ®Google Scholar
• Malcovati L, Germing U, Kuendgen A, . Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 2007;25:3503–3510.
   PubMed Web of Science ®Google Scholar
• Kantarjian H, O’Brien S, Ravandi F, . Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer 2008;113:1351–1361.
   PubMed Web of Science ®Google Scholar
• Haase D. Cytogenetic features in myelodysplastic syndromes. Ann Hematol 2008;87:515–526.
   PubMed Web of Science ®Google Scholar
• Tricot G, Boogaerts MA, De Wolf-Peeters C, . The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations. Br J Haematol 1985;59:659–670.
   PubMed Web of Science ®Google Scholar
• Knapp RH, Dewald GW, Pierre RV. Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. Mayo Clin Proc 1985;60:507–516.
   PubMed Web of Science ®Google Scholar
• Jacobs RH, Cornbleet MA, Vardiman JW, . Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 1986;67:1765–1772.
   PubMed Web of Science ®Google Scholar
• Yunis JJ, Lobell M, Arnesen MA, . Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndromes and acute myelogenous leukemia. Br J Haematol 1988;68:189–194.
   PubMed Web of Science ®Google Scholar
• Billström R, Tiede T, Hansen S, . Bone marrow karyotype and prognosis in primary myelodysplastic syndromes. Eur J Haematol 1988;41:341–346.
   PubMed Web of Science ®Google Scholar
• Nowell PC, Besa EC. Prognostic significance of single chromosome abnormalities in preleukemic states. Cancer Genet Cytogenet 1989;42:1–7.
   PubMed Web of Science ®Google Scholar
• White AD, Hoy TG, Jacobs A. Extended cytogenetic follow-up and clinical progress in patients with myelodysplastic syndromes (MDS). Leuk Lymphoma 1994;12:401–412.
   PubMed Web of Science ®Google Scholar
• Haase D, Germing U, Schanz J, . New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 2007;110:4385–4395.
   PubMed Web of Science ®Google Scholar
• Schanz J, Tüchler H, Sole F, . Proposal of a new, comprehensive cytogenetic scoring system for primary MDS. Haematologica 2010;95(Suppl. 2): Abstract 535.
   Google Scholar
• Greenberg P, Tuechler H, Schanz J, . Revised International Prognostic Scoring System (IPSS-R), developed by the International Prognostic Working Group for Prognosis in MDS (IWG-PM). Leuk Res 2011;35(Suppl. 1): Abstract 14.
   Google Scholar
• Mitelman F. An International System for Human Cytogenetic Nomenclature. Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. Memphis, TN: S. Karger; 1995.
   Google Scholar
• Chun K, Hagemeijer A, Iqbal A, . Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: an International Working Group on MDS Cytogenetics Study. Leuk Res 2010;34:160–165.
   PubMed Web of Science ®Google Scholar
• Valent P, Horny HP, Bennett JM, . Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res 2007;31:727–736.
   PubMed Web of Science ®Google Scholar
• Chen B, Zhao WL, Jin J, . Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia 2005;19:767–775.
   PubMed Web of Science ®Google Scholar
• Solé F, Espinet B, Sanz GF, . Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Br J Haematol 2000;108:346–356.
   PubMed Web of Science ®Google Scholar
• Solé F, Luno E, Sanzo C, . Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica 2005;90:1168–1178.
   PubMed Web of Science ®Google Scholar
• Schanz J, Steidl C, Fonatsch C, . Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the International Prognostic Scoring System. J Clin Oncol 2011;29:1963–1970.
   PubMed Web of Science ®Google Scholar
• Bernasconi P, Klersy C, Boni M, . World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. Br J Haematol 2007;137:193–205.
   PubMed Web of Science ®Google Scholar
• Pierre RV, Catovsky D, Mufti GJ, . Clinical-cytogenetic correlations in myelodysplasia (preleukemia). Cancer Genet Cytogenet 1989;40:149–161.
   PubMed Web of Science ®Google Scholar
• Bernasconi P, Alessandrino EP, Boni M, . Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution and survival. Am J Hematol 1994;46:270–277.
   PubMed Web of Science ®Google Scholar
• Olney HJ, Le Beau MM. The cytogenetics of myelodysplastic syndromes. Best Pract Res Clin Hematol 2001;14:479–495.
   PubMed Web of Science ®Google Scholar